Nagi Bioscience SA
Whole-organism discovery platform for healthy aging
Bioscience is a Swiss EPFL spin-off (2019) that de-risks healthy-aging and longevity R&D. Our SydLab platform is an automated "organism-on-chip" system: it runs humanized C. elegans on proprietary microfluidic chips and, in real time, images every organism and turns living biology into decision-ready, mechanistic data at scale. Pharma, biotech, nutrition and cosmetics companies use it to prove where and why an intervention works before costly animal or clinical steps. We monetize an instrument plus recurring consumables, analytics software and a growing bioassay library (60%+ recurring revenue). With 25+ customers, an install base including top industrial players, revenue doubling yearly, we are now raising a Series B to expand in the US and Asia and scale globally.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
19.06.2026
Swiss biotechs display their innovations at BIO 2026 in San Diego (startupticker.ch)
01.09.2025
New Startup Innovation Projects set to advance their technologies (startupticker.ch)
04.07.2025
23 start-ups qualified for the second stage of the Innosuisse Scale-up Coaching program (startupticker.ch)
17.04.2025
Medtechs expand their global footprint with key partners (startupticker.ch)
05.11.2024
Bio Europe in Stockholm hosts 33 Swiss companies (startupticker.ch)
Last Tweets
01.02.2025
Nagi Inc. subsidiary incorporated and active in the USA
30.03.2023
13.09.2022
No Jobs
Videos
SydLab One - Unlocking the future of micro-organisms testing
How does SydLab One work?
Get to know Nagi - From a vision to a reality
Kicking forward alternatives to animal testing
Nagi Bioscience at the TOP 100 Swiss Startup Award 2020
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Venture Leaders Life Sciences
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
Nagi Bioscience SA
Whole-organism discovery platform for healthy aging
Website:
www.nagibio.ch
Headquarter:
Saint-Sulpice
Foundation Date:
January 2019
Technology:
- Biotech
Sectors:
- Biotech
- Drug development platforms
- Drug discovery
- Micro technologies
- Machine Learning / AI
- Optics
- Robotics
- Screening
Support received
